After Britain authorized a bivalent vaccine to target Omicron, some are wondering whether they should hold out for a similar shot in the U.S.
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}After Britain authorized a bivalent vaccine to target Omicron, some are wondering whether they should hold out for a similar shot in the U.S.